FIELD: chemical-pharmaceutical industry. SUBSTANCE: composition has retinoid in an aqueous carrier containing at least a single agent preventing crystallization and stabilization. Indicated agent is taken from the group of nonionogenic surface-active substances. Composition has no alcohol. EFFECT: physical and chemical stability, retained clinical effectiveness as one containing alcohol. 13 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TOPICAL USE COMPOSITIONS CONTAINING CROSS-LINKED GLYCOSAMINOGLYCANS | 2017 |
|
RU2748750C2 |
| PERORAL COMPOSITION TO INHIBIT ACCUMULATION OF BACTERIAL PLAQUE UPON DENTINE | 1997 |
|
RU2183453C2 |
| ANTIMYCOTIC PHARMACEUTICAL COMPOSITION (VARIANTS) | 1992 |
|
RU2093152C1 |
| TOPICAL COMPOSITIONS CONTAINING N-ACYL-DIPEPTIDE DERIVATIVES AND GLYCOLIC ACID | 2020 |
|
RU2822387C2 |
| SELF-EMULSIFYING COMPOSITION FOR SCARCELY WATER-SOLUBLE MEDICAMENT | 1999 |
|
RU2257917C2 |
| COMPOSITION FOR SKIN CARE, INTENDED FOR LOCAL APPLICATION | 2003 |
|
RU2350313C2 |
| METHODS FOR IMPROVEMENT OF RETINOID ACTIVITY | 2018 |
|
RU2785545C2 |
| BIOCIDAL COMPOSITIONS OF HYDROGEN PEROXIDE WITH IMPROVED ACTIVITY | 2007 |
|
RU2437928C2 |
| COMPOSITION OF LOTION FOR PERSONAL APPLICATION | 2008 |
|
RU2463035C2 |
| OIL-IN-WATER OPHTHALMIC EMULSIONS CONTAINING PROSTAGLANDINS | 2008 |
|
RU2460516C2 |
